Loading this company
Elevance Health, Inc.
ELVPrices in USD
TickerWorth ScoreB57/100
What we think
Priced within our range of $254.30 to $630.25.
Price
$434.48USD up +$6.22 (+1.45%)
Quoted · Prices are delayed.
Why did it move today?
Nothing we can cite explains today’s move for this company.
Is it cheap?
Our range from 3 models, on today’s numbers
$254.30–$630.25
Led by discounted cash flow (DCF) · Steady cash-flow business
Delayed price used by the model $428.26Prices are delayed.
Changing the inputs, and every lens with its working, is part of Pro. See plans
Is it a good business?
- Valuation83 out of 100
- Growth50 out of 100
- Financial health100 out of 100
- Dividend75 out of 100
- Past performance67 out of 100
Bull, base, bear
Our forward range over 12 months is part of Pro. See plans
The street
Analysts’ mean target
$451.71 across 21 analysts
The high and low of the analyst range is part of Pro. See plans
What does it do?
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It operates in the Healthcare Plans industry (Healthcare sector), headquartered in United States. The company employs roughly 96,129 people.
Key stats
52-week range$274.84–$436.24
- Open
- $433.34
- Day high
- $434.00
- Day low
- $426.72
- Previous close
- $428.43
- Volume
- 1,205,967 · 1.06× avg
- Average volume
- 1,134,181
- Market cap
- $92,876,447,744.00
- P/E (TTM)
- 18.96
- Earnings per share
- $22.59
- Beta
- 0.71
Prices are delayed. The feed does not say when these figures were taken.
What’s the latest?
- Issued a public disclosure (Reg FD)
- Reported quarterly or annual results
- Issued a public disclosure (Reg FD)
- Reported shareholder vote results
- Reported quarterly or annual results
- Issued a public disclosure (Reg FD)
- Disclosed another material event
Top news
No recent headlines we can cite for this company.
Insider trades
The 90-day buying-and-selling read is part of Pro. See plans
- Kaye MarkShares withheld (tax) · $1,607,935.23
- Kaye MarkGrant / award · —
Not investment advice. TickerWorth Score is a model output.